General MedicationsORALStandard
ALVAIZ
ELTROMBOPAG CHOLINE
Standard Dose
EQ 18MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ALVAIZ is listed in Drugs@FDA under application 216774 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ELTROMBOPAG CHOLINE Form and strength TABLET;ORAL - EQ 18MG BASE Sponsor TEVA PHARMS INC Submission history Latest submission status date: 2026-01-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview ALVAIZ is listed in Drugs@FDA under application 216774 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ELTROMBOPAG CHOLINE Form and strength TABLET;ORAL - EQ 18MG BASE Sponsor TEVA PHARMS INC Submission history Latest submission status date: 2026-01-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.